The company is working in the robotics field. In its product pipeline are several unique and advantageous breakthroughs. This includes the Enos System, which offers 2D/3D vision systems and multi-articulating surgical instruments in one ergonomically designed work station. Titan is also working on licensing its products to outside companies wishing to utilize its systems.
On Wednesday, February 3rd, the company announced an upsizing to a previous bought deal offering. This is quite common as financial, and capital needs can change rapidly. Titan said that it is increasing the offering to around $20 million in gross proceeds. This consists of selling 8.335 million units at $2.40 per unit. As we’ve seen many times, the practice of capital raising in the biotech industry is quite popular. While Titan Medical does have commercialized products, this capital could help advance its R&D opportunities. Obviously, dilution is always on the table; however, the current trend is hard to ignore.
Buy for the price of 4 usd
On Wednesday, February 3rd, the company announced an upsizing to a previous bought deal offering. This is quite common as financial, and capital needs can change rapidly. Titan said that it is increasing the offering to around $20 million in gross proceeds. This consists of selling 8.335 million units at $2.40 per unit. As we’ve seen many times, the practice of capital raising in the biotech industry is quite popular. While Titan Medical does have commercialized products, this capital could help advance its R&D opportunities. Obviously, dilution is always on the table; however, the current trend is hard to ignore.
Buy for the price of 4 usd